CIRCUITRY FOR IMAGE SENSORS WITH AVALANCHE PHOTODIODES

Details for Australian Patent Application No. 2003289994 (hide)

Owner DINIZ, Pedro, N.C. QUANTUM SEMICONDUCTOR LLC AUGUSTO, Carlos, J.R.P.

Inventors DINIZ, Pedro, N.C.; AUGUSTO, Carlos, J.R.P.

Pub. Number AU-A-2003289994

PCT Number PCT/EP2003/0139

PCT Pub. Number WO2004/054235

Priority 60/431,691 09.12.02 US

Filing date 9 December 2003

Wipo publication date 30 June 2004

International Classifications

H04N 003/15 Scanning details of television systems - for picture signal generation

H01L 031/02 Semiconductor devices sensitive to infra-red radiation, light, electromagnetic radiation of shorter wavelength, or corpuscular radiation and specially adapted either for the conversion of the energy of such radiation into electrical energy or for the control of electrical energy by such radiation - Details

H04N 005/335 Details of television systems - using electrically scanned solid-state devices

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 60/431,691 09.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-A-2003289994

25 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003289995-ANHYDROUS CRYSTALLINE FORM OF VALACYCLOVIR HYDROCHLORIDE

2003289993-Chiral arylketones in the treatment of neutrophil-dependent inflammatory deseases